Agnico Eagle Mines Limited (AEM)vsAstraZeneca PLC (AZN)
AEM
Agnico Eagle Mines Limited
$193.21
+2.90%
BASIC MATERIALS · Cap: $93.89B
AZN
AstraZeneca PLC
$182.85
+0.18%
HEALTHCARE · Cap: $286.68B
Smart Verdict
WallStSmart Research — data-driven comparison
AstraZeneca PLC generates 346% more annual revenue ($60.44B vs $13.54B). AEM leads profitability with a 39.5% profit margin vs 17.2%. AZN appears more attractively valued with a PEG of 1.52. AEM earns a higher WallStSmart Score of 75/100 (B+).
AEM
Strong Buy75
out of 100
Grade: B+
AZN
Buy62
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-12.6%
Fair Value
$192.97
Current Price
$193.21
$0.24 premium
Margin of Safety
+6.6%
Fair Value
$220.34
Current Price
$182.85
$37.49 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Keeps 40 of every $100 in revenue as profit
Strong operational efficiency at 62.8%
Revenue surging 66.1% year-over-year
Earnings expanding 108.6% YoY
Conservative balance sheet, low leverage
Large-cap with strong market position
Mega-cap, among the largest globally
Every $100 of equity generates 24 in profit
Strong operational efficiency at 28.2%
Generating 1.8B in free cash flow
Areas to Watch
Expensive relative to growth rate
Expensive relative to growth rate
Moderate valuation
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : AEM
The strongest argument for AEM centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 39.5% and operating margin at 62.8%. Revenue growth of 66.1% demonstrates continued momentum.
Bull Case : AZN
The strongest argument for AZN centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 17.2% and operating margin at 28.2%. Revenue growth of 12.5% demonstrates continued momentum.
Bear Case : AEM
The primary concerns for AEM are PEG Ratio.
Bear Case : AZN
The primary concerns for AZN are PEG Ratio, P/E Ratio, Altman Z-Score.
Key Dynamics to Monitor
AEM profiles as a growth stock while AZN is a mature play — different risk/reward profiles.
AEM carries more volatility with a beta of 0.57 — expect wider price swings.
AEM is growing revenue faster at 66.1% — sustainability is the question.
AZN generates stronger free cash flow (1.8B), providing more financial flexibility.
Bottom Line
AEM scores higher overall (75/100 vs 62/100), backed by strong 39.5% margins and 66.1% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Agnico Eagle Mines Limited
BASIC MATERIALS · GOLD · USA
Agnico Eagle Mines Limited is engaged in the exploration, development and production of mineral properties in Canada, Sweden and Finland. The company is headquartered in Toronto, Canada.
Visit Website →AstraZeneca PLC
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infections, neuroscience and gastroenterology worldwide. The company is headquartered in Cambridge, the United Kingdom.
Compare with Other GOLD Stocks
Want to dig deeper into these stocks?